TY  - GEN
AU  - Zhen,Mao-Chuan
AU  - Wang,Fu-Qiang
AU  - Wu,Shao-Feng
AU  - Zhao,Yi-Lin
AU  - Liu,Ping-Guo
AU  - Yin,Zhen-Yu
TI  - Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells
SN  - 1949-2553
PY  - 2018///0222
KW  - Acetates
KW  - pharmacology
KW  - Animals
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Apoptosis
KW  - drug effects
KW  - Azocines
KW  - Benzhydryl Compounds
KW  - Benzopyrans
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Dose-Response Relationship, Drug
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Hep G2 Cells
KW  - Humans
KW  - Imidazoles
KW  - Inhibitor of Apoptosis Proteins
KW  - antagonists & inhibitors
KW  - Liver Neoplasms
KW  - Mice, Nude
KW  - Mutation
KW  - Myeloid Cell Leukemia Sequence 1 Protein
KW  - genetics
KW  - Protein Kinase Inhibitors
KW  - Protein Stability
KW  - Proteolysis
KW  - RNA Interference
KW  - Ribosomal Protein S6 Kinases, 70-kDa
KW  - Signal Transduction
KW  - TOR Serine-Threonine Kinases
KW  - Time Factors
KW  - Transfection
KW  - Triazines
KW  - Tumor Burden
KW  - Ubiquitin-Protein Ligases
KW  - X-Linked Inhibitor of Apoptosis Protein
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.18632/oncotarget.14326
ER  -